Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
25
NMPA:25
Drug Approvals
Venlafaxine Hydrochloride Sustained-Release Capsules
- Product Name
- 盐酸文拉法辛缓释胶囊
- Approval Number
- 国药准字H20254342
- Approval Date
- May 27, 2025
NMPA
Lornoxicam for Injection
- Product Name
- 注射用氯诺昔康
- Approval Number
- 国药准字H20254107
- Approval Date
- May 13, 2025
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20244949
- Approval Date
- Sep 19, 2024
NMPA
Compound Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用复方异丙托溴铵溶液
- Approval Number
- 国药准字H20243556
- Approval Date
- Apr 24, 2024
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20234472
- Approval Date
- Nov 14, 2023
NMPA
Galanthamine Hydrobromide Orally Disintegrating Tablets
- Product Name
- 氢溴酸加兰他敏口腔崩解片
- Approval Number
- 国药准字H20080769
- Approval Date
- Nov 3, 2023
NMPA
Ambzoxol Hydrochloride Granules
- Product Name
- 盐酸氨溴索颗粒
- Approval Number
- 国药准字H20184144
- Approval Date
- Mar 7, 2023
NMPA
Ambzoxol Hydrochloride Granules
- Product Name
- 盐酸氨溴索颗粒
- Approval Number
- 国药准字H20184143
- Approval Date
- Mar 7, 2023
NMPA
Roxithromycin Dispersible Tablets
- Product Name
- 罗红霉素分散片
- Approval Number
- 国药准字H20184132
- Approval Date
- Mar 7, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found